Bibliothèque

Multidisciplinary management of surgery and postoperative recurrence in stage IV gallbladder cancer following conversion therapy: a case report.

A 61-year-old female patient presented with a 10-day history of right upper abdominal pain and was subsequently diagnosed with stage IV gallbladder cancer based on preoperative imaging and pathologica…

Thérapies de Conversion

Cheng, J., Li, X., Ren, C., Yu, S., Huang, H., Zhou, S., & Dai, J. (2025). Multidisciplinary management of surgery and postoperative recurrence in stage IV gallbladder cancer following conversion therapy: a case report.. Front Oncol, 15, 1749491. https://doi.org/10.3389/fonc.2025.1749491

01/01/2025 Lire →

Exploring Social and Structural Determinants of Substance Use Among Sexual and Gender Minority Adults in the United States.

PurposeTo identify key social and structural factors associated with hazardous alcohol and problematic drug use among sexual and gender minority (SGM) adults.MethodsWe conducted a cross-sectional seco…

Thérapies de Conversion

Zhang, C., Tang, Y., Kniffen, W., & Liu, Y. (2025). Exploring Social and Structural Determinants of Substance Use Among Sexual and Gender Minority Adults in the United States.. J Int Assoc Provid AIDS Care, 24, 23259582251409855. https://doi.org/10.1177/23259582251409855

01/01/2025 Lire →

"Praying in or preying on my skin": a narrative study of transgender and gender non-conforming individuals' experiences with religion and gender identity in India.

This narrative analysis paper explores how gender non-conforming individuals interact with faith across Indian religious traditions. Drawing upon four in-depth semi-structured interviews with the part…

Neurosciences des Croyances Thérapies de Conversion

Ashok, S., & Saranya, T. S. (2025). "Praying in or preying on my skin": a narrative study of transgender and gender non-conforming individuals' experiences with religion and gender identity in India.. Front Sociol, 10, 1642404. https://doi.org/10.3389/fsoc.2025.1642404

01/01/2025 Lire →

Chemotherapy alone versus chemotherapy plus targeted therapy as adjuvant therapy for initially unresectable colorectal cancer liver metastases: a multicenter cohort study.

BACKGROUND: There is no consensus on the adjuvant treatment regimen for patients with colorectal cancer liver metastasis (CRLM) who have achieved successful conversion after surgery. This study aimed …

Thérapies de Conversion

Chang, W., Zhou, S., Guan, X., Xu, D., Liu, Y., Tang, W., Lv, Y., Qin, X., Liang, F., Wang, X., Ren, L., Fan, J., Wei, Y., Wang, X., & Xu, J. (2025). Chemotherapy alone versus chemotherapy plus targeted therapy as adjuvant therapy for initially unresectable colorectal cancer liver metastases: a multicenter cohort study.. Gastroenterol Rep (Oxf), 13, goaf098. https://doi.org/10.1093/gastro/goaf098

01/01/2025 Lire →

Pathologic complete response of advanced hepatoid adenocarcinoma of the stomach following immuno-chemotherapy and conversion surgery: a rare case report and review of the literature.

BACKGROUND: Hepatoid adenocarcinoma of the stomach (HAS) is a rare subtype of gastric cancer (GC) characterized by alpha-fetoprotein (AFP) production and invasive liver and lymph node metastases, typi…

Thérapies de Conversion

Li, Y., Wang, Y., Yu, T., Wang, D., Ma, H., Ma, J., & Da, M. (2025). Pathologic complete response of advanced hepatoid adenocarcinoma of the stomach following immuno-chemotherapy and conversion surgery: a rare case report and review of the literature.. Front Oncol, 15, 1648766. https://doi.org/10.3389/fonc.2025.1648766

01/01/2025 Lire →

Development and validation of a prognostic nomogram for unresectable pancreatic ductal adenocarcinoma with synchronous liver metastases: a study based on the SEER database and an external cohort.

BACKGROUND: Pancreatic ductal adenocarcinoma with synchronous liver metastases (PDACLM) represents a highly aggressive malignancy with limited treatment options and poor prognosis. While conversion th…

Thérapies de Conversion

Huan, L., He, Q., Cao, Y., Liu, C., & Li, Y. (2025). Development and validation of a prognostic nomogram for unresectable pancreatic ductal adenocarcinoma with synchronous liver metastases: a study based on the SEER database and an external cohort.. Front Oncol, 15, 1636715. https://doi.org/10.3389/fonc.2025.1636715

01/01/2025 Lire →

Predictors of recurrence after conversion therapy in unresectable hepatocellular carcinoma treated with HAIC, bevacizumab, and sintilimab.

BACKGROUND: Conversion therapy with hepatic arterial infusion chemotherapy (HAIC) combined with bevacizumab and sintilimab has shown promise for unresectable hepatocellular carcinoma (uHCC). However, …

Thérapies de Conversion

Liu, C. F., Zhao, X. H., Zhu, S. B., Yu, H. P., Xing, W. G., & Li, H. K. (2025). Predictors of recurrence after conversion therapy in unresectable hepatocellular carcinoma treated with HAIC, bevacizumab, and sintilimab.. Front Immunol, 16, 1644570. https://doi.org/10.3389/fimmu.2025.1644570

01/01/2025 Lire →

Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors.

OBJECTIVE: This study aimed to investigate hepatitis B virus (HBV) reactivation and its impact on postoperative survival in patients with HBV-related hepatocellular carcinoma (HCC) who underwent conve…

Thérapies de Conversion

Xu, S., Pang, Q., Wei, M., Liu, D., Yuan, D., Bai, T., Wang, X., Tang, Z., & Wu, F. (2025). Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors.. Front Cell Infect Microbiol, 15, 1598193. https://doi.org/10.3389/fcimb.2025.1598193

01/01/2025 Lire →

TACE Combined with Lenvatinib-PD-1 Versus TACE Monotherapy as Conversion Therapy Before Liver Resection in Unresectable Hepatocellular Carcinoma: A Retrospective, Propensity Score Matching Study.

BACKGROUND: Transarterial chemoembolization (TACE) combined with Lenvatinib plus programmed death-1 inhibitor (PD-1 inhibitor) is recommended for unresectable hepatocellular carcinoma (uHCC), and it h…

Thérapies de Conversion

Lu, C., Liu, R., Zhang, Y., Luo, J., Luo, C., Jiang, Z., Huang, M., Qiu, C., & Chen, J. (2025). TACE Combined with Lenvatinib-PD-1 Versus TACE Monotherapy as Conversion Therapy Before Liver Resection in Unresectable Hepatocellular Carcinoma: A Retrospective, Propensity Score Matching Study.. J Hepatocell Carcinoma, 12, 1527-1540. https://doi.org/10.2147/JHC.S517855

01/01/2025 Lire →

Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinoma.

BACKGROUND AND AIMS: Most Hepatocellular carcinoma (HCC) diagnoses occur at advanced stages precluding radical surgical resections. Conversion therapy offers a viable chance for patients with unresect…

Thérapies de Conversion

Wang, Z., Zhang, C., Yin, J., & Li, N. (2025). Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinoma.. Front Immunol, 16, 1451965. https://doi.org/10.3389/fimmu.2025.1451965

01/01/2025 Lire →

Local-region treatment comparison following conversion therapy of hepatocellular carcinoma: a period and age-dependent analysis.

BACKGROUND: Transarterial chemoembolization (TACE) is a potential conversion therapeutic strategy for unresectable hepatocellular carcinoma (uHCC). However, therapeutic options following conversion th…

Thérapies de Conversion

Hu, J., Zhao, S., Zuo, M., Li, C. H., Yao, W., Yang, X., Xing, W., & Song, P. (2025). Local-region treatment comparison following conversion therapy of hepatocellular carcinoma: a period and age-dependent analysis.. Ther Adv Med Oncol, 17, 17588359251316665. https://doi.org/10.1177/17588359251316665

01/01/2025 Lire →

Conversion Therapy for Stage IV Gastric Cancer: Report From the Expert Consensus Meeting at KINGCA WEEK 2024.

Conversion therapy is a treatment strategy that shifts from palliative systemic therapy to curative surgical treatment for primary and/or metastatic stage IV gastric cancer (GC). To address its clinic…

Thérapies de Conversion

Kim, T. H., Uyama, I., Rha, S. Y., Bencivenga, M., An, J., Wyrwicz, L., Koo, D. H., van, H. i. l. l. e. g. e. r. s. b. e. r. g. . R., Lee, K. W., Li, G., Yoshikawa, T., Badgwell, B., Lorenzen, S., Kim, I. H., Lee, I. S., Han, H. S., & Hoon, H. (2025). Conversion Therapy for Stage IV Gastric Cancer: Report From the Expert Consensus Meeting at KINGCA WEEK 2024.. J Gastric Cancer, 25(1), 133-152. https://doi.org/10.5230/jgc.2025.25.e9

01/01/2025 Lire →